NOD2 activation after injection of MDP promotes immune tolerance, lowers adipose tissue inflammation, and improves blood glucose control during low‐dose endotoxin challenge and during obesity (Cavallari et al., 2017). This evidence concerns the gene NOD2 and obesity disorder.